AG
ANAB icon

Algert Global’s AnaptysBio ANAB Stock Holding History

Algert Global’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,400
Closed -$795K – 1148
2025
Q4 		$795K Sell
16,400
-67,367
-80% -$2.63M 0.01% 888
2025
Q3 		$2.56M Buy
+83,767
New +$1.92M 0.04% 614
2025
Q2 		– Sell
-10,870
Closed -$202K – 1180
2025
Q1 		$202K Buy
+10,870
New +$181K 0.01% 1085
2024
Q3 		– Sell
-10,178
Closed -$255K – 1184
2024
Q2 		$255K Buy
10,178
+1,078
+12% +$25.1K 0.01% 1186
2024
Q1 		$205K Buy
+9,100
New +$215K 0.01% 975
2023
Q4 		– Sell
-16,530
Closed -$297K – 1121
2023
Q3 		$297K Buy
16,530
+4,740
+40% +$90.4K 0.01% 898
2023
Q2 		$240K Buy
+11,790
New +$239K 0.01% 951
2021
Q2 		– Sell
-12,240
Closed -$264K – 423
2021
Q1 		$264K Sell
12,240
-5,250
-30% -$133K 0.08% 326
2020
Q4 		$376K Sell
17,490
-34,450
-66% -$837K 0.11% 264
2020
Q3 		$766K Sell
51,940
-13,970
-21% -$252K 0.24% 148
2020
Q2 		$1.47M Hold
65,910
– – 0.5% 57
2020
Q1 		$931K Buy
+65,910
New +$1,000K 0.39% 84

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Algert Global's ANAB Position: Q1 2026 in Review

Algert Global sold out of AnaptysBio (ANAB) in Q1 2026, closing a stake of 16,400 shares — an estimated $795K sold.

Algert Global first reported a position in ANAB in Q1 2020 and held it in 12 quarters. The position peaked at $2.56M in Q3 2025. 208 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • Algert Global reported no remaining AnaptysBio position as of Q1 2026 after selling out during the quarter.
  • Algert Global sold 16,400 AnaptysBio shares in Q1 2026, an estimated $795K.
  • Algert Global first reported a position in AnaptysBio in Q1 2020 and held it in 12 quarters.
  • Algert Global's AnaptysBio position peaked at $2.56M in Q3 2025.
  • 208 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.